Kyntra Bio, Inc.
NASDAQ: KYNB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Thane Wettig
- Employees
- 225
- Headquarters
- San Francisco, United States
- IPO year
- 2014
- Market cap
- $30.6M
- Website
- https://www.kyntrabio.com
Loading KYNB…
Loading profile data…Frequently asked questions about KYNB
What does Kyntra Bio, Inc. (KYNB) do?
Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market introduction. The company's scientific focus delves into the complex biology of hypoxia-inducible factors (HIF) and connective tissue growth factors (C...
Where does KYNB trade?
Kyntra Bio, Inc. (KYNB) trades on the NASDAQ Global Market.
What sector is KYNB in?
Kyntra Bio, Inc. (KYNB) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Kyntra Bio, Inc.?
Thane Wettig is the chief executive officer of Kyntra Bio, Inc. (KYNB).
Where is Kyntra Bio, Inc. headquartered?
Kyntra Bio, Inc. is headquartered in United States.
Does KYNB pay a dividend?
Kyntra Bio, Inc. (KYNB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KYNB go public?
Kyntra Bio, Inc. (KYNB) completed its initial public offering in 2014.